Thermo Fisher Scientific Inc
TMO: XNYS (USA)
| Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
|---|---|---|---|
| LOCK|d& | LOCK|q& | LOCK|r!&SM?j> |
Thermo Fisher: Clario Acquisition Pricey but Strategically Sound
Thermo Fisher Scientific announced the acquisition of Clario Holdings, a provider of clinical trial data solutions, for $8.9 billion. The deal will close in mid-2026.
